SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Technology Stocks : BroadVision (BVSN) -- Ignore unavailable to you. Want to Upgrade?


To: Elroy who wrote (1721)7/14/1999 11:21:00 AM
From: David R. Doerr  Read Replies (1) | Respond to of 3773
 
I would buy more of the stock today if I did not have a position.

From CBS Marketplace..

But on a relative valuation basis, Inktomi is hard to swallow. Howard compared Inktomi's price-to-sales multiple to a more stable and predictable software company such as Microsoft (MSFT: news, msgs). Then there's Broadvision (BVSN: news, msgs), one of the few Net enabling companies that's profitable. Microsoft trades at some 26 times 1999 fiscal-year sales, Broadvision trades at 25 times this year's sales vs. Inktomi's 80 times this year's sales.

To be fair, Microsoft isn't the best comparison, but it's often raised as an example of a richly-priced yet proven and reliable software stock. Broadvision also has a different business model in that the company doesn't receive recurring revenue like Inktomi.